Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
Items 601–700 of 1,016
Jafari, S., Maleki‐Dizaji, N., Barar, J., Barzegar-Jalali, M., Rameshrad, M., & Adibkia, K. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.014 · Cited by 59
Umefune, G., Kogure, H., Hamada, T., Isayama, H., Ishigaki, K., Takagi, K., Akiyama, D., Watanabe, T., Takahara, N., Mizuno, S., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1278-x · Cited by 69
Wang, X., Cao, W., Zheng, C., Hu, W., & Liu, C. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.04.007 · Cited by 59
Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids
Ayyar, V. S., & Jusko, W. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018101 · Cited by 63
“Today, their therapeutic applications span diverse clinical contexts: as frontline therapy for autoimmune diseases (Kirwan, 1995; Rhen and Cidlowski, 2005), for preventing the rejection of solid organ transplants (Bergmann et al.”
BackgroundNuclear receptors in podocyte biology and glomerular disease
Agrawal, S., He, C., & Tharaux, P. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00339-6 · Cited by 62
Glucocorticoids for Acute and Persistent Postoperative Neuropathic Pain: What Is the Evidence?
Romundstad, L. G., & Stubhaug, A. (2007) · Anesthesiology · doi:10.1097/01.anes.0000279487.27940.5c · Cited by 61
Salvarani, C., Massari, M., Costantini, M., Merlo, D. F., Mariani, G. L., Viale, P., Nava, S., Guaraldi, G., Dolci, G., Boni, L., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00025-2022 · Cited by 59
“Standard treatment included dexamethasone (6 mg / day oral or intravenous for 10 days), according to the RECOVERY study protocol (2).”
BackgroundMethodMenger, L., Gouble, A., Marzolini, M. A. V., Pachnio, A., Bergerhoff, K. F., Henry, J. Y., Smith, J. N. P., Pulè, M. A., Moss, P. A. H., Riddell, S. R., et al. (2015) · Blood · doi:10.1182/blood-2015-08-664755 · Cited by 59
“It is notable that the GR is essential for the immunosuppressive effects of glucocorticoids in T cells and that loss of GR function prevents all of their apoptotic actions.(34,35) Despite the wide range of gene targets for theGR,onlyasingleGRgenehasbeendescribed,whichgenerates several GRisoformsviaalternativesplicing.”
BackgroundLeite-Júnior, J. H., Garcia, C. S. N. B., Souza-Fernandes, A. B., Silva, P. L., Ornellas, D. S., Larangeira, A. P., Castro-Faria-Neto, H. C., Morales, M. M., Negri, E. M., Capelozzi, V. L., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181847b43 · Cited by 63
“The use of corticosteroids has been proposed in the treatment of ALI/ARDS (4) because of their anti-inflammatory properties and potential effects on remodeling process (5).”
BackgroundFeraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 60
Labib, R. M., Youssef, F. S., Ashour, M. L., Abdel‐Daim, M. M., & Ross, S. A. (2017) · Molecules · doi:10.3390/molecules22091384 · Cited by 60
“In addition, hypertension, suppression of wound healing, and osteoporosis are among the common adverse effects of prolonged glucocorticoid regimen [21].”
BackgroundStellato, C. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.041 · Cited by 62
Salvi, M., Vannucchi, G. M., Campi, I., Currò, N., Simonetta, S., Covelli, D., Pignataro, L., Guastella, C., Rossi, S., Bonara, P., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.12.005 · Cited by 58
Implications of glucocorticoid therapy in idiopathic inflammatory myopathies
Hanaoka, B. Y., Peterson, C. A., Horbinski, C., & Crofford, L. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.85 · Cited by 57
A versatile toolkit for overcoming AAV immunity
Li, X., Wei, X., Lin, J., & Ou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991832 · Cited by 57
“, methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
BackgroundTomazini, B. M., Maia, I. S., Bueno, F. R., Silva, M. V. A. O., Baldassare, F. P., Costa, E. L. V., Moura, R. A. B., Honorato, M. O., Costa, A. N., Cavalcanti, A. B., et al. (2020) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20200063 · Cited by 120
“(4) Corticosteroids, due to its anti-inflammatory effects,(6) may be a suitable therapy for these patients and have been tested in different scenarios of ARDS.”
BackgroundO’Rourke, A. M., Wang, E. Y., Miller, A., Podar, E. M., Scheyhing, K., Huang, L., Kessler, C., Gao, H., Ton‐Nu, H., MacDonald, M., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131672 · Cited by 57
“LJP 1586 inhibited leukocyte trafficking to air pouches to a comparable extent to that observed with anti-LFA-1 antibody, and the reduction of infiltrating granulocytes to the lung compared favorably with dexamethasone, which has known pleiotropic effects (Rhen and Cidlowski, 2005).”
BackgroundOpposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice
Kwon, H.-J., Won, Y.-S., Park, O., Feng, D., & Gao, B. (2014) · Hepatology · doi:10.1002/hep.26748 · Cited by 58
“The actions of GCs are mediated by binding to the GC receptor (GR) and subsequently inhibiting the activity of transcription factors, which control the expression of proinflammatory cytokines, chemokines, and adhesion molecules.(21) Because of its broad antiinflammatory effects, synthetic GCs, such as prednisolone, ha…”
BackgroundNew insights into acquired endocrine resistance of breast cancer
Fan, P., & Jordan, V. C. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.13 · Cited by 63
“Our further clinically relevant findings disclose that the synthetic progestin medroxyprogesterone acetate for the classical HRT in combination with E2 has glucocorticoid activity that is able to block E2-induced apoptosis ([111]), implicating that inflammation and stress are involved in the apoptosis induced by E2 ([…”
BackgroundHuman mast cells release oncostatin M on contact with activated T cells: Possible biologic relevance
Salamon, P., Shoham, N. G., Puxeddu, I., Paitan, Y., Levi‐Schaffer, F., & Mekori, Y. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.054 · Cited by 60
Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application
Längericht, J., Kramer, I. F., & Kahaly, G. J. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820958335 · Cited by 61
Sustainable Aerobic Allylic C–H Bond Oxidation with Heterogeneous Iron Catalyst
Jiang, Y., Chen, S., Chen, Y. C., Gu, A., & Tang, C. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c12688 · Cited by 56
Sexually dimorphic actions of glucocorticoids: beyond chromosomes and sex hormones
Quinn, M. A., Ramamoorthy, S., & Cidlowski, J. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12425 · Cited by 60
Self-citationEffect of propolis on mast cells in wound healing
Barroso, P. R., Rocha, R., Pereira, E. M. F., Marinho, S. A., de Miranda, J. L., Lima, N. L., & Verli, F. D. (2011) · Inflammopharmacology · doi:10.1007/s10787-011-0105-5 · Cited by 56
Wang, Z.-M., Zhu, S., Wu, Z.-W., Lü, Y., Fu, H., & Qian, R.-Q. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.06.037 · Cited by 61
Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2009.183699 · Cited by 55
Thiazolidinediones Are Partial Agonists for the Glucocorticoid Receptor
Matthews, L. C., Berry, A. A., Tersigni, M., D’Acquisto, F., Ianaro, A., & Ray, D. W. (2008) · Endocrinology · doi:10.1210/en.2008-0196 · Cited by 56
“The GR is also a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors (24).”
BackgroundSidibeh, C. O., Pereira, M. J., Lau, J., Kamble, P. G., Skrtic, S., Katsogiannos, P., Sundbom, M., Svensson, M. K. E., & Eriksson, J. W. (2016) · Endocrine · doi:10.1007/s12020-016-1172-6 · Cited by 58
Keratinocytes control skin immune homeostasis through de novo–synthesized glucocorticoids
Phan, T. S., Schink, L., Mann, J., Merk, V. M., Zwicky, P., Mundt, S., Simon, D., Kulms, D., Abraham, S., Legler, D. F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe0337 · Cited by 59
“Despite their pleiotropic and adverse side effects, GC represent the mainstay in clinical therapy for more than 70 years, as diverse inflammatory disorders are still efficiently treated using synthetic GC ( 3 ).”
Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids
Pujols, L., Alobid, I., Benítez, P., Martínez‐Antón, A., Roca‐Ferrer, J., Fokkens, W. J., Mullol, J., & Picado, C. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01745.x · Cited by 61
“However, it cannot be ruled out that GR function – for instance its nuclear translocation, or its interaction with both the transactivating and transrepressing machinery – is altered in this or other inflammatory diseases (1, 2).”
BackgroundMethodInfluentialWeinstein, D. S., Gong, H., Doweyko, A. M., Cunningham, M., Habte, S., Wang, J. H., Holloway, D. A., Burke, C., Gao, L. J., Guarino, V. R., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200879j · Cited by 62
Oakley, R. H., Revollo, J., & Cidlowski, J. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209411109 · Cited by 55
“Because of their powerful anti-inflammatory and immunosuppressive actions, synthetic glucocorticoids are one of the most widely prescribed drugs worldwide, serving as mainstays in the treatment of acute and chronic inflammatory diseases, autoimmune diseases, organ transplant rejection, and cancers of the lymphoid syst…”
BackgroundSelf-citationDunford, E. C., & Riddell, M. C. (2016) · Metabolites · doi:10.3390/metabo6040044 · Cited by 61
“Over the past six decades, synthetic GCs have been established as an integral component of hematological cancer therapy [1] and are also used for the treatment of a variety of inflammatory conditions and diseases [2,3].”
BackgroundElevated white blood cell counts in Cushing’s disease: association with hypercortisolism
Masri‐Iraqi, H., Robenshtok, E., Tzvetov, G., Manisterski, Y., & Shimon, I. (2013) · Pituitary · doi:10.1007/s11102-013-0522-0 · Cited by 56
“Cortisol exerts its main effects through binding to the nuclear glucocorticoid receptor, inducing a cascade of intracellular signaling and leading to protein synthesis [6].”
BackgroundRijsdijk, M., van Wijck, A. J. M., Kalkman, C. J., & Yaksh, T. L. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000161 · Cited by 61
Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1
Vago, J. P., Tavares, L. P., Sugimoto, M. A., Negreiros-Lima, G. L., Galvão, I., de Caux, T. R., Lima, K. M., Ribeiro, A. L. C., Carneiro, F. S., Nunes, F. F. C., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1500886 · Cited by 59
“known anti-inflammatory drugs, and data with glucocorticoids (48) and, more recently, chromones (49) appear to corroborate the”
BackgroundThe role of Akt (protein kinase B) and protein kinase C in ischemia–reperfusion injury
Zhao, E. Y., Efendizade, A., Cai, L., & Ding, Y. (2016) · Neurological Research · doi:10.1080/01616412.2015.1133024 · Cited by 56
Bone marrow inflammation in haematological malignancies
de Jong, M. M. E., Chen, L., Raaijmakers, M. H. G. P., & Cupedo, T. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01003-x · Cited by 54
“Even though the immune-suppressive effect of corticosteroids has since been established 163 , most studies of steroid function in antitumour treatment remain focused on direct cytotoxic effects.”
Trindade, M. Â. B., Palermo, M., Pagliari, C., Valente, N. Y. S., Naafs, B., Massarollo, P. C. B., D′Albuquerque, L. A. C., & Benard, G. (2010) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2010.00549.x · Cited by 54
“Corticosteroids, on the other hand, have a broader immunosuppressive e¡ect, especially with respect to the range of target cells (25).”
BackgroundPharmacological treatments of COVID-19
Sahebnasagh, A., Avan, R., Saghafi, F., Mojtahedzadeh, M., Sadremomtaz, A., Arasteh, O., Tanzifi, A., Faramarzi, F., Negarandeh, R., Safdari, M., et al. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00152-9 · Cited by 60
Siddique, M. I., Katas, H., Amin, M. C. I. M., Ng, S., Zulfakar, M. H., Buang, F., & Jamil, A. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24666 · Cited by 58
Buttgereit, F., Zhou, H., Kalak, R., Gaber, T., Spies, C. M., Huscher, D., Straub, R. H., Modzelewski, J., Dunstan, C. R., & Seibel, M. J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24619 · Cited by 54
Noh, K. K., Chung, K. W., Choi, Y. J., Park, M. H., Jang, E. J., Park, C. H., Yoon, C., Kim, N. D., Kim, M. K., & Chung, H. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102947 · Cited by 52
“Glucocorticoids are used as therapeutic agents due to their potent anti-inflammatory and immunosuppressive functions [13].”
BackgroundEarly Dexamethasone Relieves Trigeminal Neuropathic Pain
Han, S. R., Yeo, S. P., Lee, M. K., Bae, Y. C., & Ahn, D. K. (2010) · Journal of Dental Research · doi:10.1177/0022034510374056 · Cited by 54
“Glucocorticoids block several inflammatory pathways by inhibiting prostaglandin production via the activation of annexin I, the induction of MAPK phosphatase 1, and the repression of transcription of COX-2 (Rhen and Cidlowski, 2005).”
BackgroundTalabér, G., Boldizsár, F., Bartis, D., Pàlinkàs, L., Szabó, M., Berta, G., Sétáló, G., Németh, P., & Berki, T. (2009) · International Immunology · doi:10.1093/intimm/dxp093 · Cited by 54
Cea, L. A., Balboa, E., Puebla, C., Vargas, A. A., Cisterna, B. A., Escamilla, R., Regueira, T., & Sáez, J. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.003 · Cited by 55
Muñoz-Bermúdez, R., Abella, E., Zuccarino, F., Masclans, J. R., & Nolla‐Salas, J. (2019) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v8.i5.59 · Cited by 61
Bhattacharyya, S., Ratajczak, C. K., Vogt, S. K., Kelley, C., Colonna, M., Schreiber, R. D., & Muglia, L. J. (2010) · Blood · doi:10.1182/blood-2009-06-224782 · Cited by 53
Novel therapeutic approaches for treatment of COVID-19
Hossein-khannazer, N., Shokoohian, B., Shpichka, A., Aghdaei, H. A., Timashev, P., & Vosough, M. (2020) · Journal of Molecular Medicine · doi:10.1007/s00109-020-01927-6 · Cited by 53
“Additionally, corticosteroids have an anti-inflammatory effect to diminish systemic inflammation, reduce exudative fluid in the lung tissue, and inhibit further diffused alveolar damage, which can relieve hypoxemia which can protect the lungs effectively and prevent further progression of respiratory insufficiency [10…”
BackgroundRole of pyroptosis in cancer and its therapeutic regulation
Mamun, A. A., Mimi, A. A., Aziz, M. A., Zaeem, M., Ahmed, T., Munir, F., & Xiao, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174444 · Cited by 59
Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients
Kaneko, K., Chen, H. H., Kaufman, M. W., Sverdlov, I., Stein, E. M., & Park‐Min, K. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.526 · Cited by 53
Heijnen, C. J. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.08.008 · Cited by 57
The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
Farman, N., Maubec, E., Pöeggeler, B., Klatte, J. E., Jaisser, F., & Paus, R. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01011.x · Cited by 56
Dorff, T. B., & Crawford, E. D. (2012) · Annals of Oncology · doi:10.1093/annonc/mds216 · Cited by 57
“Corticosteroids can mimic endogenous cortisol or mineralocorticoids and thus activate the glucocorticoid receptor to up-regulate expression of anti-inflammatory proteins and down-regulate expression of proinflammatory proteins [2].”
Backgroundde Lange, D. W., & Meulenbelt, J. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.553196 · Cited by 53
“Genes encoding anti-inflammatory mediators, including interleukin10, the inhibitor of nuclear factor-kB, and interleukin-1receptor antagonist, are switched on by corticosteroids.(26,27) These anti-inflammatory effects of corticosteroids could be beneficial in patients exposed to lung-damaging agents.”
BackgroundNeuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity
Zass, L. J., Hart, S. A., Seedat, S., Hemmings, S. M. J., & Malan‐Müller, S. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000143 · Cited by 55
“Owing to their lipophilic properties, glucocorticoids can cross the BBB and alter transcription in the brain (Rhen and Cidlowski, 2005).”
BackgroundInfluentialGlucocorticosteroids for people with alcoholic hepatitis
Pavlov, C. S., Varganova, D. L., Casazza, G., Tsochatzis, E. A., Nikolova, D., & Gluud, C. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001511.pub3 · Cited by 58
Kim, J.-K., Ro, D. H., Lee, H.-J., Park, J. Y., Han, H., & Lee, M. C. (2019) · The Journal of Arthroplasty · doi:10.1016/j.arth.2019.08.026 · Cited by 53
Peng, B., Xu, Q., Liu, J., Guo, S., Borgland, S. L., & Liu, S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2533-20.2020 · Cited by 56
“Corticosteroids (CORT) have been used for a variety of conditions, such as pneumonia, asthma, severe allergies, and arthritis, because of its widespread anti-inflammatory effects (Rhen and Cidlowski, 2005).”
BackgroundWhat Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?
Bikhet, M. H., Iwase, H., Yamamoto, T., Jagdale, A., Foote, J. B., Ezzelarab, M. B., Anderson, D. J., Locke, J. E., Eckhoff, D. E., Hara, H., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000003622 · Cited by 54
Takei, H., Baba, Y., Hisatsune, A., Katsuki, H., Miyata, T., Yokomizo, K., & Isohama, Y. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0072378 · Cited by 53
Corticosteroids to prevent extubation failure: a systematic review and meta-analysis
McCaffrey, J., Farrell, C., Whiting, P., Dan, A., Bagshaw, S. M., & Delaney, A. P. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1473-9 · Cited by 58
“Theoretically, corticosteroids can reduce the inflammatory response and decrease oedema [10].”
BackgroundGlucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells
D’Acquisto, F., Paschalidis, N., Raza, K., Buckley, C. D., Flower, R. J., & Perretti, M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken062 · Cited by 61
“Glucocorticoids (GCs) are extensively used for the treatment of many inflammatory and immune-mediated diseases [ 1 ].”
BackgroundNicolaides, N. C., & Charmandari, E. (2017) · Hormones · doi:10.14310/horm.2002.1728 · Cited by 52
Aharon, M. A., Prittie, J. E., & Buriko, K. (2017) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/vec.12603 · Cited by 57
IRIS Canine GN Study Group Established Pathology Subgroup, Segev, G., Cowgill, L. D., Heiene, R., Labato, M. A., & Polzin, D. J. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12228 · Cited by 54
Jung, H. H., Ji, Y. S., Sung, M. S., Kim, K. K., & Yoon, K. C. (2015) · Chonnam Medical Journal · doi:10.4068/cmj.2015.51.1.26 · Cited by 52
“Corticosteroids induce several anti-inflammatory effects.(3) For instance, they suppress inflammatory cytokines and chemokines, decrease the expression of cell adhesion molecules, and stimulate apoptosis of lymphocytes.”
Backgroundthe DEXA-ARDS Network, Villar, J., Belda, J., Añón, J. M., Blanco, J., Pérez‐Méndez, L., Ferrando, C., Martínez, D. A. S., Soler, J. A., Ambrós, A., et al. (2016) · Trials · doi:10.1186/s13063-016-1456-4 · Cited by 53
Bi, J., Yang, J., Wang, Y., Yao, C., Jing, M., Liu, Y., Cao, J., & Lu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165942 · Cited by 52
Iannarelli, R., Marinelli, O., Morelli, M. B., Santoni, G., Amantini, C., Nabissi, M., & Maggi, F. (2018) · Industrial Crops and Products · doi:10.1016/j.indcrop.2018.01.076 · Cited by 53
“Conventional therapy includes inhaled anti-inflammatory drugs such as glucocorticoids, which suppress the inflammatory process, but due to several undesired side effects, alternative treatments are needed (Rhen and Cidlowski, 2005).”
BackgroundLédée, N., Vasseur, C., Petitbarat, M., Chevrier, L., Vezmar, K., Dray, G., Chénière, S., Lobersztajn, A., Vitoux, D., Cassuto, N. G., et al. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.09.050 · Cited by 57
Advancements of Annexin A1 in inflammation and tumorigenesis
Shao, G. Q., Zhou, H., Zhang, Q., Jin, Y., & Fu, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s202271 · Cited by 57
Crosstalk between brain, lung and heart in critical care
Mrozek, S., Gobin, J., Constantin, J., Fourcade, O. A., & Geeraerts, T. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.06.016 · Cited by 59
Engelman, E. E., & Maeyens, C. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1168-0 · Cited by 52
An Integrated Biological Approach to Nuclear Receptor Signaling in Physiological Control and Disease
Carlberg, C., & Dunlop, T. W. (2006) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v16.i1.10 · Cited by 57
Bouguen, G., Dubuquoy, L., Desreumaux, P., Brunner, T., & Bertin, B. (2015) · Steroids · doi:10.1016/j.steroids.2014.12.022 · Cited by 57
“Consistent with the general immunoregulatory properties of GC [57,58], as well as the induction of intestinal steroidogenesis fol lowing immune activation, it is likely that local GC release is”
BackgroundObling, L. E. R., Beske, R. P., Meyer, M., Grand, J., Wiberg, S. C., Nyholm, B., Josiassen, J., Søndergaard, F. T., Mohr, T. T., Damm-Hejmdal, A., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-023-07247-w · Cited by 52
“Methylprednisolone also induced leukocytosis and hyperglycemia in the intervention group, both known physiological side effects to glucocorticoid treatment, during the initial three days of admission [15, 32].”
BackgroundLiposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
Kroon, J., Buijs, J. T., van der Horst, G., Cheung, H., van der Mark, M. H., van Bloois, L., Rizzo, L. Y., Lammers, T., Pelger, R. C. M., Storm, G., et al. (2015) · The Prostate · doi:10.1002/pros.22963 · Cited by 54
“Clearly, such tissue concentrations can only be achieved by high and frequent GC dosing, which inevitably entails the well-known range of detrimental GC-related side effects, providing a possible explanation for their limited use in cancer therapy [10].”
BackgroundWnt-4 Protects Thymic Epithelial Cells Against Dexamethasone-Induced Senescence
Talabér, G., Kvell, K., Varecza, Z., Boldizsár, F., Parnell, S. M., Jenkinson, E. J., Anderson, G., Berki, T., & Pongracz, J. E. (2011) · Rejuvenation Research · doi:10.1089/rej.2010.1110 · Cited by 54
“Indeed, GCs are still applied in therapy for acute and chronic autoimmune diseases and hematological malignancies, 3,4 because they effectively promote apoptosis of leukemia cells 5 and trigger complex antiin-flammatory actions by influencing both molecular and cellular components of the immune…”
Visser, L. G. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.06.003 · Cited by 56
Ishii, T., Masuzaki, H., Tanaka, T., Arai, N., Yasue, S., Kobayashi, N., Tomita, T., Noguchi, M., Fujikura, J., Ebihara, K., et al. (2007) · FEBS Letters · doi:10.1016/j.febslet.2006.11.032 · Cited by 51
“Glucocorticoids are widely used as anti-inflammatory agents in human clinics [23].”
BackgroundChuang, Y., Yang, H., Ko, T.-L., Hsu, Y.-F., Sheu, J., Ou, G., & Hsu, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.02.004 · Cited by 51
“Glucocorticoids such as dexamethasone are anti-inflammatory drugs currently used for the treatment of many inflammatory diseases [30].”
BackgroundYu, J., Cilfone, N., Large, E., Sarkar, U., Wishnok, J., Tannenbaum, Sr., Hughes, D., Lauffenburger, D., Griffith, L., Stokes, C., et al. (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12010 · Cited by 52
“In humans, HC binds to HSA and corticosteroid binding globulin (CBG) in blood, leaving a small fraction unbound(27); importantly, only the unbound form functions biologically and can be metabolized.(28,29) In our experiments, HC concentration was measured in the presence of low (1.”
Antiinflammatory Potential of Medicinal Plants: A Source for Therapeutic Secondary Metabolites
Bernstein, N., Akram, M., Daniyal, M., Koltai, H., Fridlender, M., & Gorelick, J. (2018) · Advances in agronomy · doi:10.1016/bs.agron.2018.02.003 · Cited by 56
Risks and benefits of corticosteroids in arthritic diseases in the clinic
Πέττα, Ι., Peene, I., Elewaut, D. S., Vereecke, L., & Bosscher, K. D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.009 · Cited by 54
Tsai, M., Yang, K., Chan, M.-C., Kao, K., Wang, H., Perng, W., Wu, C., Liang, S., Fang, W., Tsai, J., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0642-4 · Cited by 53
Xu, K., Lu, C., Ren, X., Wang, J., Xu, P., & Zhang, Y. (2021) · Environmental Toxicology · doi:10.1002/tox.23327 · Cited by 54
Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes
Sawmynaden, P., & Perretti, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.179 · Cited by 51
Glucocorticoid suppression of CX 3 CL1 (fractalkine) by reduced gene promoter recruitment of NF‐κB
Bhavsar, P. K., Sukkar, M. B., Khorasani, N., Lee, K., & Fan Chung, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-094235 · Cited by 51
“Glucocorticoids bind to the glucocorticoid receptor (GR), a ligand-dependent transcription factor belonging to the superfamily of steroid hormone receptors (1).”
BackgroundRegulating inflammation by glucocorticoids
Besedovsky, H. O., & del Rey, A. (2006) · Nature Immunology · doi:10.1038/ni0606-537 · Cited by 51
Tissue-specific induction of ADAMTS2 in monocytes and macrophages by glucocorticoids
Höfer, T., Frankenberger, M., Mages, J., Lang, R., Hoffmann, R. F. G., Colige, A., & Ziegler-Heitbrock, L. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0284-0 · Cited by 62
“The effects of GC on immunological functions involves potent anti-inflammatory and immunosuppressive properties [4].”
BackgroundHES1 is a master regulator of glucocorticoid receptor-dependent gene expression
Revollo, J. R., Oakley, R. H., Lu, N. Z., Kadmiel, M., Gandhavadi, M., & Cidlowski, J. A. (2013) · Science Signaling · doi:10.1126/scisignal.2004389 · Cited by 50
“Because of their hydrophobic nature, these hormones readily diffuse from the circulation into organs, tissues, and cells, where they orchestrate various physiological processes, including metabolism, energy production, immune system function, vascular tone, bone mineralization, and central nervous system function (7).”
BackgroundSelf-citationTreatment with anti‐inflammatory drugs in community‐acquired pneumonia
Meijvis, S. C. A., van de Garde, E. M. W., Rijkers, G. T., & Bos, W. J. W. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02554.x · Cited by 59
Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
Ahasan, M. M., Hardy, R., Jones, C., Kaur, K., Nanus, D., Juarez, M., Morgan, S. A., Hassan‐Smith, Z., Bénézech, C., Caamaño, J. H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34414 · Cited by 49
Mommer, B. C., & Bell, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098564 · Cited by 58
“Also, since glucocorticoids are known to affect the expression of immunityrelated genes, for example genes of the complement pathway (reviewed in [44]), we predicted an effect of maternal exposure to predation risk on the expression of genes involved in immunity.”
BackgroundHong, Y., Wu, J., Zhao, J., Wang, H., Liu, Y., Chen, T., Kan, X., Tao, Q., Shen, X., Yan, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069926 · Cited by 50
“Glucocorticoids (GCs) are small lipophilic compounds that mediate a plethora of biological effects by binding the intracellular glucocorticoid receptor (GR), which, in turn, translocates to the nucleus and directly or indirectly regulates gene transcription [1].”
BackgroundEsposito, E., Bruscoli, S., Mazzon, E., Paterniti, I., Coppo, M., Velardi, E., Cuzzocrea, S., & Riccardi, C. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0084-7 · Cited by 54
Zhang, J.-Z., Cavet, M. E., VanDerMeid, K. R., Salvador‐Silva, M., López, F. J., & Ward, K. W. (2009) · PubMed Central · Cited by 59
Farzaei, M. H., Bahramsoltani, R., Abdolghaffari, A. H., Sodagari, H. R., Esfahani, S. A., & Rezaei, N. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1145546 · Cited by 52
“diminish the late consequences of inflammation including fibroblast activation, vascular proliferation as well as deposition of collagen fibers [37].”
BackgroundAdvances in the use of prodrugs for drug delivery to the eye
Taskar, P., Tatke, A., & Majumdar, S. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1208649 · Cited by 51
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.